The blood-brain barrier and blood-retina barrier limit drug uptake

G-Technology® safely enhances brain and eye drug delivery

2-BBB develops medicines for the treatment of brain and eye diseases

We believe that we can transform the lives of those affected faster and more successful by combining known disease targets and compounds with established drug delivery systems united with safe targeting technology. This has led to two programs in clinical development for the treatment of brain cancer and neuro-inflammatory diseases.


Technology

Technology

At the heart of 2-BBB’s CNS drug delivery platform lays the G-Technology®, a proprietary CNS targeted liposome formulation.

lead programs

Lead Programs

We have the following lead programs:

Company

Company 2-BBB

2-BBB started as a spin-off company from the Blood-Brain Barrier Research Group of the Leiden Academic Center for Drug Research (LACDR) from Leiden University in the Netherlands to develop medicines for the treatment of devastating brain diseases.


 2-BBB’S TECHNOLOGY PROVIDES A SAFE AND PROPRIETARY 
BRAIN AND EYE DRUG DELIVERY PLATFORM